SCHEMBL14680283

SCHEMBL14680283

Oc1cc2cc(O)c(-c3cccc4ccccc34)cc2cc1-c1cccc2ccccc12

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.54
TRPM4 Q8TD43 1/20 0.50
MCL1 Q07820 1/20 0.49
ACMSD Q8TDX5 1/20 0.49
GPR84 Q9NQS5 1/20 0.46
ALDH1A1 P00352 3/20 0.45
HPGD P15428 3/20 0.45
HSD17B10 Q99714 3/20 0.45
TSHR P16473 2/20 0.45
MAPK1 P28482 2/20 0.45
CASP1 P29466 2/20 0.45
HIF1A Q16665 2/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
PTPN22 Q9Y2R2 1/20 0.45
NQO2 P16083 1/20 0.43
KDM4E B2RXH2 2/20 0.43
ALPL P05186 1/20 0.43
GAA P10253 1/20 0.43
ESR1 P03372 1/20 0.42
ESR2 Q92731 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26153496 0.91 CYP1A2 (0.58) CYP1A2TRPM4MCL1ACMSDGPR84
SCHEMBL30214159 0.82 CYP1A2 (0.65) CYP1A2TRPM4MCL1ACMSDALDH1A1
SCHEMBL30502980 0.82 ALDH1A1 (0.56) CYP1A2GPR84ALDH1A1HPGDHSD17B10
SCHEMBL217637 0.82 CYP1A2 (0.65) CYP1A2TRPM4MCL1ACMSDALDH1A1
SCHEMBL93762 0.82 ESR2 (0.50) CYP1A2MCL1ACMSDALDH1A1HPGD
SCHEMBL4037425 0.81 ALDH1A1 (0.58) CYP1A2GPR84ALDH1A1HPGDHSD17B10
SCHEMBL25302086 0.81 ALDH1A1 (0.59) CYP1A2ALDH1A1HPGDHSD17B10TSHR
SCHEMBL29350007 0.81 ALDH1A1 (0.59) CYP1A2ALDH1A1HPGDHSD17B10TSHR
SCHEMBL27953 0.81 ALDH1A1 (0.59) CYP1A2ALDH1A1HPGDHSD17B10TSHR
SCHEMBL11782188 0.80 MCL1 (0.64) CYP1A2MCL1ACMSDALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8963813-B2 Organic compound and organic light emitting device having the same CANON KABUSHIKI KAISHA (JP) 2015-02-24 US disclosed
US-8963813-B2 Organic compound and organic light emitting device having the same CANON KABUSHIKI KAISHA (JP) 2015-02-24 US disclosed
US-20130033416-A1 ORGANIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE HAVING THE SAME CANON KABUSHIKI KAISHA (JP) 2013-02-07 US disclosed
US-20130033416-A1 ORGANIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE HAVING THE SAME CANON KABUSHIKI KAISHA (JP) 2013-02-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130033416-A1 ORGANIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE HAVING THE SAME TRPA1, OCIAD1, BMP2 CYP1A2 107/4885TRPM4 83/4885MCL1 2155/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.